School of Medicine
Showing 1-10 of 49 Results
-
Ragini Adams
Clinical Assistant Professor, Pediatrics - Hematology & Oncology
Current Research and Scholarly InterestsCirculating tumor DNA (ctDNA) is DNA that is released by tumor cells into the blood of the host; it is a fraction of all the cell free DNA (cfDNA) that is present. Because ctDNA contains the mutations of the original tumor, it is detectable using next generation sequencing and is an accurate surrogate measure of tumor burden. Therefore, ctDNA is an emerging biomarker in Hodgkin Lymphoma (HL) that is specific, quantifiable, and can be measured by noninvasive means. Using ctDNA to explore the genetic landscape of pediatric HL and monitor the response of these patients to therapy has never been done before and is my current focus of study.
-
Catherine Aftandilian
Clinical Associate Professor, Pediatrics - Hematology & Oncology
Current Research and Scholarly InterestsI conduct clinical research on the prevention, early diagnosis, and treatment of infectious complications in pediatric patients with leukemia.
-
Harvey Cohen
Deborah E. Addicott - John A. Kriewall and Elizabeth A. Haehl Family Professor of Pediatrics
Current Research and Scholarly InterestsMy research interests extend from hypothesis-driven studies in biochemistry and cell biology to discovery-driven interests in proteomics and systems biology to clinical treatment of acute lymphoblastic leukemia of children, and pediatric palliative care.
-
Jacquelyn Nicole Crane
Clinical Assistant Professor, Pediatrics - Hematology & Oncology
BioDr. Jacquelyn Crane is a Clinical Assistant Professor in the Pediatric Hematology Oncology division at Lucile Packard Children’s Hospital, Stanford University School of Medicine. She received her undergraduate degree from Dartmouth College. She then conducted laboratory-based genetics research for two years in the Pauls lab at Massachusetts General Hospital. She received her medical degree from Tufts University School of Medicine and completed her pediatrics residency and pediatric hematology/oncology fellowship training at University of California Los Angeles. As a pediatric hematology & oncology fellow, she engaged in computational analysis of osteosarcoma transcriptomic data in the Graeber Lab and completed a medical education fellowship certificate program. Her primary clinical and research interests include sarcomas and other solid tumors, cancer genomics, clinical trials and medical education. She is the associate program director of the pediatric hematology-oncology fellowship.
-
Gary Dahl
Professor of Pediatrics (Hematology/Oncology), Emeritus
Current Research and Scholarly InterestsHematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.
-
Heike Daldrup-Link
Professor of Radiology (General Radiology) and, by courtesy, of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsAs a physician-scientist involved in the care of pediatric patients and developing novel pediatric molecular imaging technologies, my goal is to link the fields of nanotechnology and medical imaging towards more efficient diagnoses and image-guided therapies. Our research team develops novel imaging techniques for improved cancer diagnosis, for image-guided-drug delivery and for in vivo monitoring of cell therapies in children and young adults.
-
Kara Davis
Assistant Professor of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsChildhood cancers can be considered aberrations of normal tissue development. We are interested in understanding childhood cancers through the lens of normal development. Further, individual tumors are composed of heterogeneous cell populations, not all cells being equal in their ability to respond to treatment or to repopulate a tumor. Thus, we take single cell approach to determine populations of clinical relevance.